Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

This was the stock's eighth consecutive day of losses.

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming MS management across the health care system.

--Longest losing streak since Oct. 27, 2023, when it fell for eight straight trading days --Worst eight day stretch since the eight days ending May 15, 2025, when it fell 9.88% --Down 45.31% from its ...

That’s pushing up the values of companies with a heavy Medicare presence, such as UnitedHealth, Humana and CVS Health, which also reported earnings this morning.

Rising prescription drug costs remain a top healthcare concern, with pharmacy benefit managers (PBMs) facing heightened scrutiny for their role in managing prescription drug benefits for insurers and ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Fort Sheridan Advisors dramatically reduced its CVS Health stake by over 60%, selling 5,130 shares in the first quarter.

CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings ...

This was the stock's second consecutive day of losses.

Responding to criticism over everyday items locked behind glass security cases, CVS told The Independent, “Retail theft is a ...

With CVS implementing security measures against theft, columnist Matt Bai suggested these tactics are ruining the shopping ...